Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Cash from Operations (2018 - 2025)

Neurogene (NGNE) has disclosed Cash from Operations for 5 consecutive years, with 19464000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash from Operations fell 24.71% year-over-year to 19464000.0, compared with a TTM value of 77196000.0 through Sep 2025, down 29.64%, and an annual FY2024 reading of 70603000.0, down 37.3% over the prior year.
  • Cash from Operations was 19464000.0 for Q3 2025 at Neurogene, roughly flat from 19462000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 15607000.0 in Q3 2024 and bottomed at 21650000.0 in Q1 2024.